Dr. Rosellini is an Associate Professor in the Department of Epidemiology and School of Public Health. He also holds an adjunct appointment in the Department of Psychological and Brain Sciences and at the Center for Anxiety and Related Disorders, where he was previously a Research Assistant Professor (2016-2022).
Dr. Rosellini studies the etiology and course of anxiety and mood disorders – also known as internalizing psychopathology. His research uses a combination of clinical psychological and epidemiologic methods to:
(1) Identify and understand the emotional, psychological, and environmental factors (e.g., personality, emotion regulation, stress, trauma) associated with the development and persistence of internalizing psychopathology.
(2) Develop clinically-usefully risk tools that optimally predict the onset, severity, course, and treatment response of internalizing psychopathology and associated behavioral outcomes (e.g., suicide).
(3) Improve clinical assessment, diagnosis, and classification
Dr. Rosellini received his Ph.D. in clinical psychology from Boston University. He previously worked as a Research Associate in the Department of Health Care Policy at Harvard Medical School, where he also completed a postdoctoral fellowship in psychiatric epidemiology.
Diversity, Equity, Inclusion and Accessibility
-I believe it is unethical to engage in research that could maintain or exacerbate discrimination, stigma, or inequity, and that it is necessary to anticipate how research findings could lead to such outcomes. I critically evaluate my own research questions and findings from the perspective of how they might impact diversity, equity, and inclusivity.
-I have collaborated with several students (e.g., through UROP) on DEIA-focused projects using publicly available data sources (e.g., examining the association between income inequality and depression severity; how discrimination and stigma impacts mental health among LGBT populations).
-I try to foster a open, safe, and nonjudgmental environment where mentees and students are comfortable sharing their ideas, opinions, and goals. Students and trainees must feel safe to test out theories and be wrong, and teachers must demonstrate that they are nonjudgmental when discussing concepts and answering questions.
-I teach Mental Health Epidemiology (SPH EP790) and am currently revising the syllabus using the BUSPH Syllabus Assessment Tool, to ensure that the course is consistent with the school's commitment to advancing diversity, equity, inclusion, and justice.
-I serve on the BUSPH Diversity, Equity, Inclusion, and Justice Committee (DEIJ-C) as a Departmental Representative (Epidemiology). I also am a member of the BUSPH Department of Epidemiology Antiracism Committee (ARC)
-Between 2016 and 2022, I served as the co-chair of Boston University’s Clinical Psychology Colloquium Committee (Department of Psychological and Brain Sciences). A central mission of the Colloquium Committee was to invite scholars from underrepresented groups to speak about issues related to DEIA (e.g., neuroscientific basis of prejudice and dehumanization)
-My training as a cognitive-behavioral therapist has greatly impacted how I think about issues related to diversity, equity, and inclusivity in my research, mentorship, and teaching. I completed my clinical internship training year at the University of Mississippi Medical Center/VA Medical Center in Jackson, Mississippi, an area with among the highest rates of poverty and health problems in the United States. As a graduate student, I completed a clinical placement at a methadone clinic located off Mass Ave and close to BUMC, providing cognitive-behavioral and 12-step based treatments to individuals with opioid use disorders, several of whom were homeless.
Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety
09/01/2022 - 06/30/2027 (PI)NIH/National Institute of Mental Health3R01MH128377-02S1
Personnel Agreement for Research Services of Anthony Rosellini
05/01/2023 - 04/30/2024 (Key Person)
PI: Jaimie L. Gradus, DMSc, DSc, MPHVA Maryland Health Care System
Interpersonnel Agreement for Anthony Rosellini
08/01/2020 - 07/31/2022 (PI)VA Boston Healthcare System
Using Causal Inference and Machine Learning Methods to Predict Cognitive Behavioral Treatment Response
04/09/2019 - 02/28/2022 (PI)NIH/National Institute of Mental Health5R21MH119492-02
Developing Risk Algorithms of Internalizing Disorder Etiology and Course
12/01/2016 - 08/31/2020 (PI)NIH/National Institute of Mental Health5K01MH106710-05
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 94 results.
Gradus JL, Smith ML, Szentkúti P, Rosellini AJ, Horváth-Puhó E, Lash TL, Galea S, Schnurr PP, Sumner JA, Sørensen HT. Antihypertensive Medications and PTSD Incidence in a Trauma Cohort. J Clin Psychiatry. 2023 Aug 02; 84(5).View Related Profiles. PMID: 37530605; PMCID: PMC10545136; DOI: 10.4088/JCP.22m14767;
Umemoto A, Zhou Z, Millon EM, Koshy CS, Taylor SM, Spann MN, Monk C, Marsh R, Rosellini AJ, Auerbach RP. Intergenerational transmission of cognitive control capacity among children at risk for depression. Biol Psychol. 2023 Sep; 182:108652. PMID: 37516422; PMCID: PMC10528753; DOI: 10.1016/j.biopsycho.2023.108652;
Vogt D, Rosellini AJ, Borowski S, Street AE, O'Brien RW, Tomoyasu N. How well can U.S. military veterans' suicidal ideation be predicted from static and change-based indicators of their psychosocial well-being as they adapt to civilian life? Soc Psychiatry Psychiatr Epidemiol. 2023 Jun 08.View Related Profiles. PMID: 37291331
Yamin N, Brown TA, Rosellini AJ. Longitudinal associations of chronic health stress and COVID-19-related anxiety among outpatients with anxiety and mood disorders. Clin Psychol Psychother. 2023; 30(5):1020-1028. PMID: 37073862
Galiano CS, Andrea AM, Brown TA, Rosellini AJ. Direct and Interactive Effects of Personality and Experiencing Changes in Relationships on Symptoms of Internalizing Psychopathology During the COVID-19 Pandemic. Cognit Ther Res. 2023; 47(3):327-339. PMID: 37168695; PMCID: PMC10018602; DOI: 10.1007/s10608-023-10364-x;
Sampson L, Gradus JL, Cabral HJ, Rosellini AJ, Fink DS, Cohen GH, Liberzon I, Galea S. Stressful life events and incident depression among U.S. military personnel. Soc Psychiatry Psychiatr Epidemiol. 2023 Jul; 58(7):1009-1018.View Related Profiles. PMID: 36897335
Rosellini AJ, Andrea AM, Galiano CS, Hwang I, Brown TA, Luedtke A, Kessler RC. Developing Transdiagnostic Internalizing Disorder Prognostic Indices for Outpatient Cognitive Behavioral Therapy. Behav Ther. 2023 May; 54(3):461-475. PMID: 37088504; PMCID: PMC10126479; DOI: 10.1016/j.beth.2022.11.004;
Rosellini, AJ, Osma, J, Suso, C, Brown, TA. In T Farchione & J Osma (Eds.), Applications of the Unified Protocol for Transdiagnostic Treatment of Emotional Dysregulation in Health Conditions. Transdiagnostic emotional disorder assessment and case formulation in health conditions. Oxford University Press. New York. 2022; (in press).
Rosellini, AJ, Brown, TA. In A Tasman, MB Riba, TG Schulze, CH Ng, CA Alfonso, D Lecic-Tosevski, S Kanba, RD Alarcon, & DM Ndetei (Eds.), Tasman’s Psychiatry. Generalized anxiety disorder. Springer. New York. 2022; (in press).
Smith ML, Seegulam V, Szentkúti P, Horváth-Puhó E, Galea S, Lash TL, Rosellini AJ, Schnurr PP, Sørensen HT, Gradus JL. Risk of psychopathology following traumatic events among immigrants and native-born persons in Denmark. Soc Psychiatry Psychiatr Epidemiol. 2023 Sep; 58(9):1305-1316.View Related Profiles. PMID: 36449069; DOI: 10.1007/s00127-022-02391-y;
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.